Overview
About Alpha-1 Foundation
The Alpha-1 Foundation (A1F) is committed to finding a cure for Alpha-1 Antitrypsin Deficiency (Alpha-1) and to improving the lives of people affected by Alpha-1 worldwide. A1F is a not-for-profit Florida corporation founded in 1995 by John Walsh, Sandy Lindsey, and Susan Stanley, three individuals diagnosed with Alpha-1. A majority of the Board of Directors are either diagnosed with Alpha-1 or have a family member diagnosed with Alpha-1.
A1F has invested more than $100 million to support Alpha-1 research and programs at 130 institutions in North America, Europe, the Middle East, and Australia.
Follow us on social media for up-to-date Alpha-1 news and information:
Facebook - Alpha1Foundation
Twitter - alphafriend
Instagram - Alpha1Foundation
A1F has invested more than $100 million to support Alpha-1 research and programs at 130 institutions in North America, Europe, the Middle East, and Australia.
Follow us on social media for up-to-date Alpha-1 news and information:
Facebook - Alpha1Foundation
Twitter - alphafriend
Instagram - Alpha1Foundation